Personalized Medicine in Oncology September 2014

Page 1

Unifying Oncologists & Pathologists

A Peer-Reviewed Journal September 2014 • Volume 3 • Number 6

PM O

BIOMARKERS • TARGETED THERAPIES • DIAGNOSTICS

Personalized Medicine in Oncology TM

INTERVIEW WITH THE INNOVATORS Tissue Phenomics: Closing the Gap Between Genomic Information and Patient Outcomes. An Interview With Thomas P. Heydler, CEO of Definiens............................................Page 314

IMMUNOTHERAPY FDA Approves Pembrolizumab for Advanced Melanoma....................................Page 320

HEMATOLOGIC MALIGNANCIES Highlights From the 6th International Symposium Acute Promyelocytic Leukemia......................Page 324

LUNG CANCER Navigating the Molecular Testing Landscape in Lung Cancer.................................................. Page 334

VALUE-BASED CANCER CARE Determining the Value of Cancer Therapies: A Paradigm Shift Focused on Quality, Outcomes, and Cost........................................................Page 348

THE LAST WORD The Personalized Medicine Coalition and Turning the Tide Against Cancer Through Sustained Medical Innovation.......................Page 350 GLOBAL BIOMARKERS

CONSORTIUM Clinical Approaches to Targeted Technologies ™

The official publication of

GLOBAL BIOMARKERS CONSORTIUM Clinical Approaches to Targeted Technologies ™

WORLD CUTANEOUS MALIGNANCIES CONGRESS

© 2014 Green Hill Healthcare Communications, LLC An affiliation of The Lynx Group

WORLD CUTANEOUS

In partnership with


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.